SENP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.838790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.540400E-01
Normal-vs-Stage2
1.782370E-01
Normal-vs-Stage3
3.231700E-02
Normal-vs-Stage4
5.784800E-01
Stage1-vs-Stage2
6.310000E-01
Stage1-vs-Stage3
1.783900E-02
Stage1-vs-Stage4
7.249000E-01
Stage2-vs-Stage3
6.663600E-02
Stage2-vs-Stage4
4.665200E-01
Stage3-vs-Stage4
2.143700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.898210E-01
Normal-vs-AfricanAmerican
4.220400E-01
Normal-vs-Asian
1.071220E-01
Caucasian-vs-AfricanAmerican
7.743600E-01
Caucasian-vs-Asian
2.031200E-01
AfricanAmerican-vs-Asian
3.343600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.197200E-01
Normal-vs-Female
1.605240E-01
Male-vs-Female
6.815400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.049800E-01
Normal-vs-Age(41-60Yrs)
4.699400E-01
Normal-vs-Age(61-80Yrs)
1.066570E-01
Normal-vs-Age(81-100Yrs)
1.203800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.870200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.686600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.918800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.700700E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.429900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.016000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.143500E-02
Normal-vs-Daily Drinker
3.296500E-02
Normal-vs-Weekly Drinker
1.550020E-01
Normal-vs-Occasional Drinker
3.708200E-01
Normal-vs-Social Drinker
5.051600E-01
Non Drinker-vs-Daily Drinker
9.265800E-01
Non Drinker-vs-Weekly Drinker
6.024000E-01
Non Drinker-vs-Occasional Drinker
9.290100E-02
Non Drinker-vs-Social Drinker
5.412100E-02
Daily Drinker-vs-Weekly Drinker
5.612000E-01
Daily Drinker-vs-Occasional Drinker
9.475900E-02
Daily Drinker-vs-Social Drinker
5.741800E-02
Weekly Drinker-vs-Occasional Drinker
3.790200E-01
Weekly Drinker-vs-Social Drinker
2.703200E-01
Occasional Drinker-vs-Social Drinker
7.595600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.412600E-01
Normal-vs-Grade 2
1.337580E-01
Normal-vs-Grade 3
7.330300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.048600E-01
Grade 1-vs-Grade 3
9.597200E-01
Grade 1-vs-Grade 4
2.412600E-01
Grade 2-vs-Grade 3
6.844400E-01
Grade 2-vs-Grade 4
1.337580E-01
Grade 3-vs-Grade 4
7.330300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.213800E-02
Normal-vs-NonDiabetic
1.384780E-01
Diabetic-vs-NonDiabetic
6.785600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.786200E-02
Normal-vs-NoPancreatitis
1.568370E-01
Pancreatitis-vs-NoPancreatitis
2.245000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.148200E-01
Normal-vs-N1
1.823790E-01
N0-vs-N1
8.851400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.801800E-01
Normal-vs-TP53-NonMutant
4.046400E-01
TP53-Mutant-vs-TP53-NonMutant
9.030200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
